A coalition of public health researchers released two health policy briefs on 6 November 2025 that frame the deportation and immigration enforcement practices in the […]
Author Archives: Ethan Hoffmann
Causes of Antibiotic-Resistant Bacteria
Antibiotic-resistant bacteria are specific strains of bacterial species that have developed resistance from the effects of antibacterial agents due to continued exposure. Take note that […]
Mpox: How Is Mpox Virus Transmitted?
The monkeypox virus or MPOXV is a double-stranded DNA virus that belongs to the Orthopoxvirus genus in the Poxviridae family. It is a disease-causing and […]
Banning Flavored E-Cigarettes Increases Traditional Cigarette Use Among Young Adults
Research published in September 2025 in Health Economics has revealed that comprehensive state bans on flavored e-cigarettes or vaporized nicotine products may be unintentionally driving […]
These Social Factors Can Double or Triple Long COVID Risk
A study, conducted by researchers at Mass General Brigham, found a strong link between social risk factors and the development of long COVID. The research, […]
Cytokine Storm: Definition, Causes, and Effects
A cytokine storm is a condition characterized by an uncontrolled and excessive release of inflammatory cytokines. More specifically, it is a physiological reaction observed in […]
Orforglipron from Lilly is a Daily Oral GLP-1 Pill for Weight Loss and Diabetes
American multinational pharmaceutical company Eli Lilly and Company has been testing its daily oral glucagon-like peptide-1 or GLP-1 pill called Orforglipron. More recent results, including […]
COVID-19 mRNA Vaccines May Help the Immune System Fight Cancer
The mRNA vaccines that protected billions from COVID-19 may also hold an unexpected benefit against cancer. A new study published on 22 October 2025 in […]
This Gene Causes Obesity But Also Protects Against Heart Disease
Researchers studying the melanocortin-4 receptor or MC4R gene discovered that some people with mutations in this gene become obese yet remain unexpectedly protected from high […]
Pelage Raises $120M to Advance Its Hair Loss Reversal Topical Drug
Pelage Pharmaceuticals announced on 15 October 2025 that it had secured a Series B financing round worth 120 million U.S. dollars. The company plans to […]